Roland
G. Kallen, M.D., Ph.D.
Professor, Dept of Biochemistry
& Biophysics
913B Stellar-Chance Bldg.
422 Curie Blvd
Philadelphia, PA 19104-6059
Tel: 215-898-5184 Fax: 215-573-7058
E-mail: rgk@mail.med.upenn.edu
(internet)
http://www.med.upenn.edu/bmbgrad/Faculty/Master_List/Kallen/kallen.html
/ins/faculty/kallen.htm Click here for selected publications since Dr. Kallen's arrival at Penn
RESEARCH INTERESTS
Ion channel mediated transmembrane signal transduction. What do channels
look like, how do they work in the presence and absence of modifiers and
what regulates their expression of voltage-sensitive sodium channels in
normal and pathologic states?
RESEARCH TECHNIQUES
Recombinant DNA (DNA, RNA, protein blots, site-specific mutagenesis, purification
and characterization of nucleic acids and proteins, exploitation of expression
and overexpression systems, etc.); tissue culture (skeletal muscle and cardiac
cells); cytochemistry involving antibody and nucleic acid probes; analysis
of transgenic animals expressing abnormal channels; generation and expression
of synthetic mRNAs in oocytes, and mammalian cells; voltage- and patch-clamp
analysis
RESEARCH SUMMARY
Skeletal muscle, brain and cardiac voltage-dependent sodium channels:
The electrical action potential responsible for muscle contraction involves
the sodium channel and by employing molecular biological techniques we
have cloned, sequenced and overexpressed cDNA clones for these ion channels.
We have analyzed naturally occuring human mutations and constructed site-specific
mutants. In addition we have cloned and investigated the promoter regions
of the genes encoding these channels. The aim of these studies are two-fold:
(a) to understand how the change in subtype patterns following birth and
denervation affects organ function; (b) to study the biochemistry of the
channels via structure-function correlations which will enable an understanding
of which parts of the molecule are involved in various channel states
(activated, inactivated, closed), sites of drug and toxin binding, and
the topological arrangement of the channel in the membrane. These studies
may help to understand why there are so many different channel subtypes
and to determine the defects in sodium channels associated with human
diseases such as familial hyperkalemic periodic paralysis and paramyotonia
congenita, which we have shown to be linked to one sodium channel gene
and for which we have developed a transgenic mouse model. This will enable
pathophysiological studies and allow us to assess new therapeutic modalities.
Finally, we are exploring the use of fluorescence resonance energy transfer
measurements, which will give distance measurements between specifically
labeled sites on the channel, created by recombinant DNA methods. This
promises to provide a quantum jump in our comprehension of the detailed
3-D structure. This is a prerequisite for understanding how these important
membrane proteins work.
KEY WORDS:
Structure; function; expression; ion channels
|